Giant Lymph Node Hyperplasia
7 clinical trials · Condition
◉ Watch Giant Lymph Node Hyperplasia
| Record | Firm | Date |
|---|---|---|
| International Registry for Patients With Castleman Disease (NCT02817997) | University of Pennsylvania | 2016-10-01 |
| Unlock the Cell: Castleman's Disease Flow Cytometry Study (NCT02853968) | University of Pennsylvania | 2016-02-01 |
| Tocilizumab for KSHV-Associated Multicentric Castleman Disease (NCT01441063) | National Cancer Institute (NCI) | 2011-09-13 |
| Valganciclovir to Treat HHV-8 Associated Multicentric Castleman's Disease (NCT00361933) | University of Washington | 2008-12-01 |
| A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease (NCT00412321) | Centocor, Inc. | 2005-05-01 |
| Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy (NCT00127569) | French National Agency for Research on AIDS and Viral Hepatitis | 2003-05-01 |
Track Giant Lymph Node Hyperplasia automatically
Every clearance here is in the API, with alerts when new ones post.